Subependymal giant cell astrocytoma historical perspective: Difference between revisions
No edit summary |
|||
| (15 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Subependymal giant cell astrocytoma}} | {{Subependymal giant cell astrocytoma}} | ||
{{CMG}}{{AE}}{{SR}} | {{CMG}}{{AE}} {{SR}}, {{IO}} | ||
==Overview== | ==Overview== | ||
Subependymal giant cell astrocytoma was described as a [[lesion]] located in the caudothalamic groove having a size of >1 cm in any direction or a subependymal [[lesion]] that has shown serial growth on consecutive imaging regardless of size and location. | |||
==Historical Perspective== | ==Historical Perspective== | ||
* | *In 2012, experts at the International Tuberous Sclerosis Complex Consensus Conference described subependymal giant cell atroctyoma as a [[lesion]] located in the caudothalamic groove having a size of >1 cm in any direction or a subependymal lesion that has shown serial growth on consecutive imaging regardless of size and location.<ref name="pmid31428037">{{cite journal| author=Jansen AC, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P et al.| title=Newly Diagnosed and Growing Subependymal Giant Cell Astrocytoma in Adults With Tuberous Sclerosis Complex: Results From the International TOSCA Study. | journal=Front Neurol | year= 2019 | volume= 10 | issue= | pages= 821 | pmid=31428037 | doi=10.3389/fneur.2019.00821 | pmc=6688052 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31428037 }} </ref> | ||
== | ==References== | ||
{{reflist| | {{reflist|1}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
| Line 20: | Line 19: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Latest revision as of 18:03, 5 November 2019
|
Subependymal giant cell astrocytoma Microchapters |
|
Differentiating Subependymal Giant Cell Astrocytoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Subependymal giant cell astrocytoma historical perspective On the Web |
|
American Roentgen Ray Society Images of Subependymal giant cell astrocytoma historical perspective |
|
FDA on Subependymal giant cell astrocytoma historical perspective |
|
CDC on Subependymal giant cell astrocytoma historical perspective |
|
Subependymal giant cell astrocytoma historical perspective in the news |
|
Blogs on Subependymal giant cell astrocytoma historical perspective |
|
Risk calculators and risk factors for Subependymal giant cell astrocytoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2], Ifeoma Odukwe, M.D. [3]
Overview
Subependymal giant cell astrocytoma was described as a lesion located in the caudothalamic groove having a size of >1 cm in any direction or a subependymal lesion that has shown serial growth on consecutive imaging regardless of size and location.
Historical Perspective
- In 2012, experts at the International Tuberous Sclerosis Complex Consensus Conference described subependymal giant cell atroctyoma as a lesion located in the caudothalamic groove having a size of >1 cm in any direction or a subependymal lesion that has shown serial growth on consecutive imaging regardless of size and location.[1]
References
- ↑ Jansen AC, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P; et al. (2019). "Newly Diagnosed and Growing Subependymal Giant Cell Astrocytoma in Adults With Tuberous Sclerosis Complex: Results From the International TOSCA Study". Front Neurol. 10: 821. doi:10.3389/fneur.2019.00821. PMC 6688052 Check
|pmc=value (help). PMID 31428037.